Wu Shu-Fen, Ching Ching-Yun, Lee Hui-Yen, Tung Hong-Yi, Juan Chien-Wei, Chao Tung-Bo
MS, RN, Department of Nursing, Yuan's General Hospital, and Adjunct Lecturer, Department of Health Business Administration, Meiho University, Taiwan, ROC.
BSN, RN, Department of Nursing, Yuan's General Hospital, Taiwan, ROC.
Hu Li Za Zhi. 2015 Dec;62(6):68-80. doi: 10.6224/JN62.6.68.
Quality of life is increasingly used as a primary outcome measure in studies that are designed to evaluate the effectiveness of treatment in cancer survivors.
Analyze the symptom distress, depression, and quality of life in colorectal cancer patients and explore the relationship of related variables with changes in QoL (quality of life) during and after treatment.
A cross-sectional study design was used for the present study. Patients (N = 138) with colorectal cancer were recruited from a district hospital in southern Taiwan. Data were collected using a self-report questionnaire. Questionnaire scales included the M.D. Anderson Symptom Inventory-Taiwan Form, the Center for Epidemiologic Studies Depression Scale, and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core-30 Version 3 in Chinese as well as a demographic and disease-related variables datasheet. Descriptive data were presented using percentage, mean, and standard deviation. Chi-square test, independent t-test, one-way ANOVA, and hierarchical multiple regression were used for inferential statistics.
The post-treatment group showed a significantly higher average global health QOL score (68.68 vs. 59.54; p < .05). Hierarchical regression showed that the impact factor of quality of life has a depressive effect in many dimensions. The second most significant variable was symptom distress. Symptoms interfered with life activity functions and family income and impacted negatively on patient treatment. In survivorship, depressive tendencies was the variable that was most affected, followed by recurrence, symptoms interference, and surgical treatment, respectively. When controlling for the relevant variables, these predictors accounted for 38.5% and 40.9% of the total variance of global health quality of life.
CONCLUSIONS / IMPLICATIONS FOR PRACTICE: This study demonstrates that personal characteristics variables, depressive tendencies, and symptom distress all impact on the quality of life of colorectal cancer patients in terms of receiving treatment and survivorship. These findings imply that healthcare professionals must provide appropriate emotional support in order to decrease depression tendency at different stages. Thus, these patients should receive nursing interventions that effectively decrease depression and symptom distress and enhance quality of life at different disease stages.
生活质量越来越多地被用作旨在评估癌症幸存者治疗效果的研究中的主要结局指标。
分析结直肠癌患者的症状困扰、抑郁和生活质量,并探讨相关变量与治疗期间及治疗后生活质量(QoL)变化的关系。
本研究采用横断面研究设计。从台湾南部的一家地区医院招募了138例结直肠癌患者。使用自填式问卷收集数据。问卷量表包括台湾版MD安德森症状量表、流行病学研究中心抑郁量表、中文版欧洲癌症研究与治疗组织生活质量问卷核心30版第3版以及一份人口统计学和疾病相关变量数据表。描述性数据以百分比、均值和标准差表示。采用卡方检验、独立t检验、单因素方差分析和分层多元回归进行推断性统计。
治疗后组的平均总体健康生活质量得分显著更高(68.68对59.54;p <.05)。分层回归显示,生活质量的影响因素在多个维度上具有抑郁效应。第二显著的变量是症状困扰。症状干扰了生活活动功能和家庭收入,并对患者治疗产生负面影响。在生存期间,抑郁倾向是受影响最大的变量,其次分别是复发、症状干扰和手术治疗。在控制相关变量后,这些预测因素分别占总体健康生活质量总方差的38.5%和40.9%。
结论/对实践的启示:本研究表明,个人特征变量、抑郁倾向和症状困扰在接受治疗和生存方面均对结直肠癌患者的生活质量产生影响。这些发现意味着医疗保健专业人员必须提供适当的情感支持,以在不同阶段降低抑郁倾向。因此,这些患者应接受有效的护理干预,以在不同疾病阶段减轻抑郁和症状困扰,提高生活质量。